Nutex Health Gains Approval for Dual Listing on Nasdaq Texas, Expanding Market Presence

Nutex Health Gains Approval for Dual Listing on Nasdaq Texas

Nutex Health Inc., a prominent player in the healthcare sector, has recently announced an exciting development: the company has secured approval for a dual listing of its common stock on Nasdaq Texas. This strategic move is expected to boost Nutex Health's visibility among regional investors while continuing to trade on the Nasdaq Global Market under its ticker symbol, NUTX.

The dual listing on Nasdaq Texas is scheduled to commence on or around September 23, 2026. This decision aligns with Nutex Health's focus on expanding its market presence, particularly as its corporate headquarters and senior leadership team are based in Houston, Texas. Tom Vo, M.D., MBA, Chairman and CEO of Nutex Health, expressed his pride in establishing a presence on Nasdaq Texas, emphasizing the benefits it brings to the company’s visibility among local institutional investors.

Founded in 2011, Nutex Health operates a physician-led healthcare management company with a diverse range of operations. With 28 hospital facilities across 12 states, the company is dedicated to innovative healthcare solutions that emphasize primary care and risk-bearing physician networks. The company's multi-faceted approach includes a Hospital Division that focuses on the ownership and management of micro-hospitals and specialty hospitals, a Population Health Management Division that oversees provider networks, and a Real Estate Division that handles the development and construction of healthcare facilities.

The upcoming dual listing does not necessitate any actions from existing shareholders. Shares of Nutex Health's common stock will remain fully fungible across both trading venues, ensuring seamless transactions for investors. This decision underscores the company's commitment to providing accessible trading options and robust growth potential for its investors.

In addition to the dual listing announcement, Nutex Health has filed a registration statement on Form 8-A with the U.S. Securities and Exchange Commission (SEC). This filing is part of the necessary steps to comply with the regulatory requirements for the dual listing under Section 12(b) of the Securities Exchange Act of 1934.

The healthcare industry is subject to various challenges and uncertainties, and Nutex Health is aware of the potential risks involved. The company has acknowledged potential challenges, including regulatory uncertainties, ongoing litigation, competition, and the need to secure future financing. By keeping investors informed about these risks, Nutex Health aims to promote transparency and trust among its shareholders.

As Nutex Health looks ahead, the company remains focused on its growth strategy and its commitment to revolutionizing healthcare delivery. By embracing innovative models and fostering an efficient healthcare ecosystem, Nutex Health demonstrates its dedication to improving healthcare access and outcomes for patients throughout the nation.

In conclusion, Nutex Health Inc.'s approval for a dual listing on Nasdaq Texas marks a significant milestone in its growth journey. With its solid presence on the Nasdaq Global Market and now on Nasdaq Texas, the company is poised to enhance its outreach and engagement with institutional investors. As they embark on this exciting chapter, Nutex Health is committed to delivering high-quality healthcare services and innovative solutions to better serve communities across the United States.